| scholarly article | Q13442814 |
| P50 | author | Graciela S Alarcón | Q67485107 |
| John D Reveille | Q67485113 | ||
| Jaime Calvo-Alén | Q91866349 | ||
| LUMINA Study Group | Q114722503 | ||
| P2093 | author name string | Gerald McGwin | |
| Luis M Vilá | |||
| Mónica Fernández | |||
| Rosa Andrade | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| Is research into ethnicity and health racist, unsound, or important science? | Q28756356 | ||
| Ethnicity as a variable in epidemiological research | Q36886820 | ||
| Race, ethnicity, culture, and science. | Q42592876 | ||
| P433 | issue | 4 | |
| P921 | main subject | lupus erythematosus | Q188297 |
| multiethnicity | Q111242702 | ||
| systemic lupus erythematosus | Q1485 | ||
| patient | Q181600 | ||
| P304 | page(s) | 576-584 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. | |
| P478 | volume | 57 |
| Q36843735 | A novel polymorphism of the human CD40 receptor with enhanced function |
| Q35223839 | A retrospective analysis of clinical presentation of lupus nephritis |
| Q37593029 | Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations |
| Q37695854 | Allelic-dependent expression of an activating Fc receptor on B cells enhances humoral immune responses |
| Q47349515 | An invisible student population: Accommodating and serving college students with lupus |
| Q90465816 | Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort |
| Q37365433 | CD40 and autoimmunity: the dark side of a great activator. |
| Q36663933 | Characterization of Patients With Lupus Nephritis Included in a Large Cohort From the Spanish Society of Rheumatology Registry of Patients With Systemic Lupus Erythematosus (RELESSER). |
| Q38906343 | Chinese SLE Treatment and Research Group (CSTAR) registry:VIII. Influence of socioeconomic and geographical variables on disease phenotype and activity in Chinese patients with SLE. |
| Q36653353 | Chronic kidney disease in United States Hispanics: a growing public health problem. |
| Q38798798 | Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis |
| Q31122937 | Clinical manifestations and coronary artery disease risk factors at diagnosis of systemic lupus erythematosus: data from an international inception cohort |
| Q34610794 | Clinical presentations and outcomes of Filipino juvenile systemic lupus erythematosus |
| Q33423725 | Comparison of clinical and serological differences among juvenile-, adult-, and late-onset systemic lupus erythematosus in Korean patients. |
| Q94521105 | Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities |
| Q47823630 | Cytokine balance and behavioral intervention; findings from the Peer Approaches to Lupus Self-Management (PALS) project. |
| Q53102157 | Damage in lupus patients--what have we learned so far? |
| Q35638534 | Depression in patients with rheumatoid arthritis: description, causes and mechanisms |
| Q36528425 | Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study |
| Q48465443 | Development of a conceptual model of health-related quality of life for systemic lupus erythematosus from the patient's perspective. |
| Q34580224 | Differential TRAF3 utilization by a variant human CD40 receptor with enhanced signaling |
| Q42957622 | Disease activity patterns in juvenile systemic lupus erythematosus and its relation to early aggressive treatment |
| Q37413878 | Disparities in lupus care and outcomes |
| Q44369790 | Disparities in renal replacement in lupus nephritis: current practice and future implications |
| Q36747908 | Early Life Factors Associated with Adult-Onset Systemic Lupus Erythematosus in Women |
| Q39392025 | Effective Self-Management Interventions for Patients With Lupus: Potential Impact of Peer Mentoring |
| Q51140299 | Efficacy and safety of rituximab in comparison with common induction therapies in pediatric active lupus nephritis. |
| Q34518097 | Elevated C-reactive protein and self-reported disease activity in systemic lupus erythematosus. |
| Q35082426 | End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. |
| Q60960470 | Engaging African ancestry participants in SLE clinical trials |
| Q37778652 | Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus |
| Q37069392 | Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004 |
| Q53839415 | Epidemiology of systemic lupus erythematosus. |
| Q46496211 | Ethnicity in systemic lupus erythematosus (SLE): its influence on susceptibility and outcomes |
| Q43752384 | European ancestry decreases the risk of early onset, severe lupus nephritis in a single center, multiethnic pediatric lupus inception cohort |
| Q37398821 | European genetic ancestry is associated with a decreased risk of lupus nephritis |
| Q26829554 | Genes associated with SLE are targets of recent positive selection |
| Q34047556 | Genetic Adaptation and Neandertal Admixture Shaped the Immune System of Human Populations |
| Q39272890 | HLA-DRB1*15 confers susceptibility to juvenile SLE but is not associated with disease presentation: an Egyptian Study |
| Q57143219 | Healthcare resource utilization and costs associated with long-term corticosteroid exposure in patients with systemic lupus erythematosus |
| Q28069750 | I too, am America: a review of research on systemic lupus erythematosus in African-Americans |
| Q37010357 | Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations. |
| Q90594989 | Implementation and dissemination of an African American popular opinion model to improve lupus awareness: an academic-community partnership |
| Q34555870 | Increased Education is Associated with Decreased Compliance in an Urban Multi-Ethnic Lupus Cohort |
| Q43156843 | Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients? |
| Q47151713 | Low incidence of opportunistic Infections in Lupus Patients treated with Cyclophosphamide and Steroids in a Tertiary care setting |
| Q38549420 | Lupus (SLE): Existence and Impact of Depressive Symptomatology |
| Q45183938 | Lupus and community-based social work |
| Q38362113 | Lupus in Latin-American patients: lessons from the GLADEL cohort. |
| Q24643421 | MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis |
| Q26774815 | Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives |
| Q30839806 | Missed opportunities for timely diagnosis of pediatric lupus in South Africa: a qualitative study |
| Q38777083 | Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis. |
| Q42211485 | Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis |
| Q47743761 | Mortality from systemic erythematosus lupus in Brazil: evaluation of causes according to the government health database |
| Q58576759 | My life with lupus: contextual responses of African-American women with systemic lupus participating in a peer mentoring intervention to improve disease self-management |
| Q38585887 | Mycophenolate mofetil for lupus nephritis: an update |
| Q34975939 | Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis |
| Q34946314 | PTPN22 association in systemic lupus erythematosus (SLE) with respect to individual ancestry and clinical sub-phenotypes |
| Q38035938 | Patients with lupus: an overview of culturally competent practice |
| Q92827719 | Peer approaches to self-management (PALS): comparing a peer mentoring approach for disease self-management in African American women with lupus with a social support control: study protocol for a randomized controlled trial |
| Q35992226 | Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study |
| Q53694045 | Phenome-wide association study identifies marked increased in burden of comorbidities in African Americans with systemic lupus erythematosus. |
| Q58052078 | Plasminogen activator inhibitor-1 polymorphisms (−844 G>A and HindIII C>G) in systemic lupus erythematosus: association with clinical variables |
| Q34534055 | Polymorphisms in the non-muscle myosin heavy chain gene (MYH9) are associated with lower glomerular filtration rate in mixed ancestry diabetic subjects from South Africa. |
| Q81563984 | Poverty, not ethnicity, accounts for the differential mortality rates among lupus patients of various ethnic groups |
| Q47697086 | Predictors and outcome of systemic lupus erythematosus (SLE) admission rates in a large teaching hospital in sub-Saharan Africa |
| Q46335304 | Predictors of premature gonadal failure in patients with systemic lupus erythematosus. Results from LUMINA, a multiethnic US cohort (LUMINA LVIII). |
| Q37851849 | Pregnancy outcomes in Japanese patients with SLE: retrospective review of 55 pregnancies at a university hospital |
| Q36587996 | Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population |
| Q42663522 | Preventive health services for systemic lupus erythematosus patients: whose job is it? |
| Q33455990 | Protective effect of hydroxychloroquine on renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort |
| Q35195820 | Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox. |
| Q33411232 | Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort |
| Q39069721 | Retrospective review of lupus nephritis in a New Zealand multi-ethnic cohort |
| Q33497970 | Risk factors and impact of recurrent lupus nephritis in patients with systemic lupus erythematosus undergoing renal transplantation: data from a single US institution |
| Q38928061 | Role of psychosocial reserve capacity in anxiety and depression in patients with systemic lupus erythematosus. |
| Q26853280 | Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions |
| Q31129756 | Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV). |
| Q38798999 | Socioeconomic Status Contributes to Racial/Ethnic Disparities in Adverse Pregnancy Outcomes among Women with Systemic Lupus Erythematosus |
| Q26768534 | Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway |
| Q55282858 | Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. |
| Q37921757 | Systemic lupus erythematosus in Hispanics |
| Q46458870 | The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project |
| Q46080575 | The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort |
| Q45021635 | The clinical manifestations and survival of systemic lupus erythematosus patients in Turkey: report from two centers |
| Q38784456 | The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. |
| Q57226203 | The effects of cyclophosphamide and mycophenolate on end-stage renal disease and death of lupus nephritis |
| Q36932364 | The impact of skin damage due to cutaneous lupus on quality of life |
| Q37137299 | Time to neuropsychiatric damage occurrence in LUMINA (LXVI): a multi-ethnic lupus cohort |
| Q38686467 | Towards new avenues in the management of lupus glomerulonephritis |
| Q34845661 | Trans-ancestral studies fine map the SLE-susceptibility locus TNFSF4. |
| Q35927877 | Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study |
| Q33621131 | Understanding the epidemiology and progression of systemic lupus erythematosus |
| Q50041214 | Understanding the factors that influence risk tolerance among minority women: A qualitative study. |
| Q38011226 | Utilizing registries in systemic lupus erythematosus clinical research |
Search more.